Patient Guide: A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 10 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06953960
Status: 🟢 Enrolling Now
Condition: Multiple Myeloma
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 10 locations across the country.

Top locations include:
  • • Tacoma, Washington
  • • Ramat Gan, Tel-Aviv
  • • Haifa,
  • • And 7 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM) - Join Clinical Trial NCTNCT06953960

How to Join This Clinical Trial - NCTNCT06953960

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Multiple Myeloma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Myeloma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Myeloma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06953960 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 10 locations. Find a study site near you:

Clinical Research Site

Tacoma, Washington 98405 - United States

Status: RECRUITING

Clinical Research Site

Ramat Gan, Tel-Aviv 5265601 - Israel

Status: RECRUITING

Clinical Research Site

Haifa, 3525408 - Israel

Status: RECRUITING

Clinical Research Site

Jerusalem, 91120 - Israel

Status: RECRUITING

Clinical Research Site

Petah Tikva, 4941492 - Israel

Status: RECRUITING

Clinical Research Site

Nagoya, Aichi 467-8602 - Japan

Status: RECRUITING

Clinical Research Site

Kyoto-shi, Kyoto 602-8566 - Japan

Status: RECRUITING

Clinical Research Site

Suita-shi, Osaka 565-0871 - Japan

Status: RECRUITING

Clinical Research Site

Minato-ku, Tokyo 105-8471 - Japan

Status: RECRUITING

Clinical Research Site

Shibuya-ku, Tokyo 150-8935 - Japan

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Multiple Myeloma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships